Lariviere Y, Garcia-Fogeda I, Zola Matuvanga T, Isekah Osang'ir B, et al. Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo. J Infect Dis 2023 Aug 24:jiad350. doi: 10.1093.
PMID: 37673423